奥锐特(605116)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

605116 奥锐特

已收盘 03-20 15:00:00

{"stockData":{"symbol":"605116","market":"SH","secType":"STK","nameCN":"奥锐特","latestPrice":25.94,"timestamp":1773990001000,"preClose":25.95,"halted":0,"volume":3986000,"delay":0,"changeRate":-0.0004,"floatShares":405999999,"shares":405999999,"eps":1.0452,"marketStatus":"已收盘","change":-0.01,"latestTime":"03-20 15:00:00","open":25.72,"high":26.54,"low":25.72,"amount":104000000,"amplitude":0.0316,"askPrice":25.95,"askSize":63,"bidPrice":25.94,"bidSize":7,"shortable":0,"etf":0,"ttmEps":1.0452,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774229400000},"marketStatusCode":5,"adr":0,"adjPreClose":25.95,"symbolType":"stock","openAndCloseTimeList":[[1773970200000,1773977400000],[1773982800000,1773990000000]],"highLimit":28.55,"lowLimit":23.36,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":406183234,"isCdr":false,"pbRate":4.18,"roa":"--","peRate":24.818217,"roe":"14.37%","epsLYR":0.89,"committee":-0.149367,"marketValue":10536000000,"turnoverRate":0.0098,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-03-23。","floatMarketCap":10536000000},"requestUrl":"/m/hq/s/605116","defaultTab":"news","newsList":[{"id":"2621799676","title":"每周股票复盘：奥锐特（605116）获恩扎卢胺片药品注册批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2621799676","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621799676?lang=zh_cn&edition=full","pubTime":"2026-03-22 02:51","pubTimestamp":1774119068,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘，奥锐特报收于25.94元，较上周的25.7元上涨0.93%。本周关注点公司公告汇总：奥锐特获恩扎卢胺片药品注册批件，用于多种前列腺癌治疗。2026年3月16日，褚义舟减持45.0万股，占总股本0.1108%，当日收盘价26.51元，期间股价上涨3.15%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032200000746.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605116","BK0239"],"gpt_icon":0},{"id":"2620242073","title":"奥锐特：3月16日董事褚义舟减持股份合计45万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2620242073","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620242073?lang=zh_cn&edition=full","pubTime":"2026-03-17 21:24","pubTimestamp":1773753862,"startTime":"0","endTime":"0","summary":"证券之星消息，根据3月17日市场公开信息、上市公司公告及交易所披露数据整理，奥锐特(605116)最新董监高及相关人员股份变动情况：2026年3月16日公司董事褚义舟共减持公司股份45.0万股，占公司总股本为0.1108%。变动期间公司股价上涨3.15%，3月16日当日收盘报26.51元。奥锐特近半年内的董监高及核心技术人员增减持详情如下：    奥锐特的高管列表及最新持股情况如下：    该股最近90天内共有3家机构给出评级，买入评级3家。为证券之星据公开信息整理，由AI算法生成(网信算备310104345710301240019号)，不构成投资建议。","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202603/17/20260317292299.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202603/17/20260317292299.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260317/32075809.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["605116","BK0239"],"gpt_icon":0},{"id":"2619046164","title":"奥锐特（605116）披露获得恩扎卢胺片药品注册批件，3月16日股价上涨3.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2619046164","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619046164?lang=zh_cn&edition=full","pubTime":"2026-03-16 22:20","pubTimestamp":1773670840,"startTime":"0","endTime":"0","summary":"截至2026年3月16日收盘，奥锐特报收于26.51元，较前一交易日上涨3.15%，最新总市值为107.68亿元。奥锐特药业股份有限公司近日收到国家药品监督管理局核准签发的两份恩扎卢胺片《药品注册证书》，批准该药品用于转移性激素敏感性前列腺癌、非转移性去势抵抗性前列腺癌及转移性去势抵抗性前列腺癌成年患者的治疗。该产品获批符合药品注册要求，但后续生产销售仍受政策、市场等因素影响，存在不确定性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031600036682.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605116","BK0239"],"gpt_icon":0},{"id":"2619507774","title":"奥锐特：3月13日董事褚义舟减持股份合计46万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2619507774","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619507774?lang=zh_cn&edition=full","pubTime":"2026-03-16 20:01","pubTimestamp":1773662507,"startTime":"0","endTime":"0","summary":"证券之星消息，根据3月16日市场公开信息、上市公司公告及交易所披露数据整理，奥锐特（605116）最新董监高及相关人员股份变动情况：2026年3月13日公司董事褚义舟共减持公司股份46.0万股，占公司总股本为0.1132%。变动期间公司股价上涨0.27%，3月13日当日收盘报25.7元。奥锐特近半年内的董监高及核心技术人员增减持详情如下：奥锐特的高管列表及最新持股情况如下：该股最近90天内共有3家机构给出评级，买入评级3家。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031600031659.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605116"],"gpt_icon":0},{"id":"2619643042","title":"奥锐特(605116.SH)：恩扎卢胺片获药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2619643042","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619643042?lang=zh_cn&edition=full","pubTime":"2026-03-16 15:47","pubTimestamp":1773647264,"startTime":"0","endTime":"0","summary":"智通财经APP讯，奥锐特(605116.SH)公告，公司收到国家药品监督管理局核准签发的两份恩扎卢胺片《药品注册证书》。公告显示，恩扎卢胺是第二代雄激素受体(AR)抑制剂，对AR具有更高的亲和力。它不仅能够有效阻断双氢睾酮与AR的结合，还能进一步抑制AR的核易位及其与DNA的转录结合，从而更彻底地阻断雄激素受体信号通路。该药物作用具有高特异性，仅拮抗AR，不会引起雄激素撤退综合征。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414272.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"奥锐特(605116.SH)：恩扎卢胺片获药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","605116"],"gpt_icon":0},{"id":"2619944611","title":"奥锐特：3月12日董事褚义舟减持股份合计29万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2619944611","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619944611?lang=zh_cn&edition=full","pubTime":"2026-03-13 20:01","pubTimestamp":1773403310,"startTime":"0","endTime":"0","summary":"证券之星消息，根据3月13日市场公开信息、上市公司公告及交易所披露数据整理，奥锐特（605116）最新董监高及相关人员股份变动情况：2026年3月12日公司董事褚义舟共减持公司股份29.0万股，占公司总股本为0.0714%。变动期间公司股价下跌0.66%，3月12日当日收盘报25.63元。奥锐特近半年内的董监高及核心技术人员增减持详情如下：奥锐特的高管列表及最新持股情况如下：该股最近90天内共有3家机构给出评级，买入评级3家。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031300036475.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605116"],"gpt_icon":0},{"id":"2618131203","title":"奥锐特：3月11日董事褚义舟减持股份合计35万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2618131203","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618131203?lang=zh_cn&edition=full","pubTime":"2026-03-12 20:01","pubTimestamp":1773316893,"startTime":"0","endTime":"0","summary":"证券之星消息，根据3月12日市场公开信息、上市公司公告及交易所披露数据整理，奥锐特（605116）最新董监高及相关人员股份变动情况：2026年3月11日公司董事褚义舟共减持公司股份35.0万股，占公司总股本为0.0862%。变动期间公司股价下跌1.23%，3月11日当日收盘报25.8元。奥锐特近半年内的董监高及核心技术人员增减持详情如下：奥锐特的高管列表及最新持股情况如下：该股最近90天内共有3家机构给出评级，买入评级3家。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031200034652.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605116","BK0239"],"gpt_icon":0},{"id":"2618553859","title":"奥锐特：3月9日董事褚义舟减持股份合计28.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2618553859","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618553859?lang=zh_cn&edition=full","pubTime":"2026-03-10 21:12","pubTimestamp":1773148321,"startTime":"0","endTime":"0","summary":"证券之星消息，根据3月10日市场公开信息、上市公司公告及交易所披露数据整理，奥锐特(605116)最新董监高及相关人员股份变动情况：2026年3月9日公司董事褚义舟共减持公司股份28.5万股，占公司总股本为0.0702%。变动期间公司股价上涨0.9%，3月9日当日收盘报25.75元。奥锐特近半年内的董监高及核心技术人员增减持详情如下：    奥锐特的高管列表及最新持股情况如下：    该股最近90天内共有3家机构给出评级，买入评级3家。为证券之星据公开信息整理，由AI算法生成(网信算备310104345710301240019号)，不构成投资建议。","market":"us","thumbnail":" http://caiji.3g.cnfol.com/colect/202603/10/20260310438523.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202603/10/20260310438523.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260310/32058166.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","605116"],"gpt_icon":0},{"id":"2618255086","title":"奥锐特：3月6日高管褚义舟减持股份合计32万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2618255086","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618255086?lang=zh_cn&edition=full","pubTime":"2026-03-09 20:02","pubTimestamp":1773057722,"startTime":"0","endTime":"0","summary":"证券之星消息，根据3月9日市场公开信息、上市公司公告及交易所披露数据整理，奥锐特（605116）最新董监高及相关人员股份变动情况：2026年3月6日公司董事褚义舟共减持公司股份32.0万股，占公司总股本为0.0788%。变动期间公司股价上涨2.28%，3月6日当日收盘报25.52元。奥锐特近半年内的董监高及核心技术人员增减持详情如下：奥锐特的高管列表及最新持股情况如下：该股最近90天内共有3家机构给出评级，买入评级3家。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030900030529.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605116"],"gpt_icon":0},{"id":"2617427885","title":"奥锐特：3月4日高管褚义舟减持股份合计1100股","url":"https://stock-news.laohu8.com/highlight/detail?id=2617427885","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617427885?lang=zh_cn&edition=full","pubTime":"2026-03-05 20:46","pubTimestamp":1772714782,"startTime":"0","endTime":"0","summary":"证券之星消息，根据3月5日市场公开信息、上市公司公告及交易所披露数据整理，奥锐特(605116)最新董监高及相关人员股份变动情况：2026年3月4日公司董事褚义舟共减持公司股份1100.0股，占公司总股本为0.0003%。变动期间公司股价下跌1.36%，3月4日当日收盘报24.66元。奥锐特近半年内的董监高及核心技术人员增减持详情如下：    奥锐特的高管列表及最新持股情况如下：    该股最近90天内共有3家机构给出评级，买入评级3家。为证券之星据公开信息整理，由AI算法生成(网信算备310104345710301240019号)，不构成投资建议。","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202603/05/20260305264513.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202603/05/20260305264513.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260305/32047863.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["605116","BK0239"],"gpt_icon":0},{"id":"2616532068","title":"奥锐特：3月3日高管褚义舟减持股份合计15.4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2616532068","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616532068?lang=zh_cn&edition=full","pubTime":"2026-03-04 20:01","pubTimestamp":1772625703,"startTime":"0","endTime":"0","summary":"证券之星消息，根据3月4日市场公开信息、上市公司公告及交易所披露数据整理，奥锐特（605116）最新董监高及相关人员股份变动情况：2026年3月3日公司董事褚义舟共减持公司股份15.4万股，占公司总股本为0.0379%。变动期间公司股价下跌2.08%，3月3日当日收盘报25.0元。奥锐特近半年内的董监高及核心技术人员增减持详情如下：奥锐特的高管列表及最新持股情况如下：该股最近90天内共有3家机构给出评级，买入评级3家。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030400036360.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605116"],"gpt_icon":0},{"id":"2608085130","title":"2月2日奥锐特跌7.08%，建信高端医疗股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2608085130","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608085130?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:39","pubTimestamp":1770021566,"startTime":"0","endTime":"0","summary":"证券之星消息，2月2日奥锐特跌7.08%，收盘报26.66元，换手率1.68%，成交量6.81万手，成交额1.86亿元。重仓奥锐特的公募基金请见下表：该股最近90天内共有2家机构给出评级，买入评级2家。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为建信基金的建信高端医疗股票A。该公募基金现任基金经理为马牧青。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200023384.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","159891","605116"],"gpt_icon":0},{"id":"2608070541","title":"每周股票复盘：奥锐特（605116）董事褚义舟拟减持不超0.98%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2608070541","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608070541?lang=zh_cn&edition=full","pubTime":"2026-02-01 04:11","pubTimestamp":1769890270,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，奥锐特报收于28.69元，较上周的31.29元下跌8.31%。本周，奥锐特1月26日盘中最高价报31.27元。本周关注点公司公告汇总：董事褚义舟因个人资金需求，计划减持不超过公司总股本的0.98%。公司公告汇总奥锐特药业股份有限公司董事褚义舟持有公司股份112,294,800股，占总股本的27.65%，股份来源为IPO前取得。因个人资金需求，褚义舟计划自公告发布之日起15个交易日后3个月内，通过集中竞价方式减持不超过400万股，即不超过公司总股本的0.98%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020100001527.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605116","BK0239"],"gpt_icon":0},{"id":"2606237506","title":"每周股票复盘：奥锐特（605116）完成6002万股份回购","url":"https://stock-news.laohu8.com/highlight/detail?id=2606237506","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606237506?lang=zh_cn&edition=full","pubTime":"2026-01-25 03:35","pubTimestamp":1769283311,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘，奥锐特报收于31.29元，较上周的34.43元下跌9.12%。本周，奥锐特1月19日盘中最高价报35.58元，股价触及近一年最高点。本次回购股份资金总额不低于6,000万元且不高于12,000万元，回购股份用于转换公司可转债。回购完成后，公司总股本由406,195,000股变更为406,183,234股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012500001297.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605116"],"gpt_icon":0},{"id":"2605548341","title":"奥锐特（605116）披露股份回购实施结果暨股份变动公告，1月21日股价下跌1.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605548341","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605548341?lang=zh_cn&edition=full","pubTime":"2026-01-21 22:37","pubTimestamp":1769006230,"startTime":"0","endTime":"0","summary":"截至2026年1月21日收盘，奥锐特报收于31.15元，较前一交易日下跌1.27%，最新总市值为126.53亿元。公告称，公司于2025年1月21日至2026年1月20日实施股份回购，累计回购股份2,778,338股，占公司总股本的0.68%，实际回购金额为60,028,504.68元，回购价格区间为18.83元/股至33.00元/股。本次回购股份资金总额不低于6,000万元且不高于12,000万元，回购股份用于转换公司可转债。回购完成后，公司总股本由406,195,000股变更为406,183,234股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012100041194.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605116"],"gpt_icon":0},{"id":"2604213026","title":"股市必读：奥锐特（605116）1月19日收盘跌6.04%，主力净流入2095.54万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2604213026","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604213026?lang=zh_cn&edition=full","pubTime":"2026-01-20 02:25","pubTimestamp":1768847109,"startTime":"0","endTime":"0","summary":"截至2026年1月19日收盘，奥锐特报收于32.35元，下跌6.04%，换手率2.34%，成交量9.49万手，成交额3.16亿元。当日关注点来自交易信息汇总：奥锐特1月19日收盘报32.35元，跌6.04%，主力资金当日净流入443.56万元。来自交易信息汇总：前10个交易日主力资金累计净流入1404.62万元，期间股价累计上涨23.3%。该股最近90天内共有2家机构给出评级，买入评级2家。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012000000929.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605116"],"gpt_icon":0},{"id":"2604923305","title":"每周股票复盘：奥锐特（605116）回购价上限调至35.00元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2604923305","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604923305?lang=zh_cn&edition=full","pubTime":"2026-01-18 02:30","pubTimestamp":1768674629,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘，奥锐特报收于34.43元，较上周的30.69元上涨12.19%。本周，奥锐特1月16日盘中最高价报34.8元，股价触及近一年最高点。1月13日盘中最低价报29.7元。奥锐特当前最新总市值139.85亿元，在化学制药板块市值排名39/150，在两市A股市值排名1497/5183。本次调整无需提交股东大会审议。截至公告日，公司已累计回购股份2,627,238股，占总股本的0.65%，支付资金总额55,124,396.68元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011800000541.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605116","BK0239"],"gpt_icon":0},{"id":"2602354699","title":"奥锐特（605116）披露调整回购价格上限，1月12日股价上涨0.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602354699","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602354699?lang=zh_cn&edition=full","pubTime":"2026-01-12 22:31","pubTimestamp":1768228272,"startTime":"0","endTime":"0","summary":"截至2026年1月12日收盘，奥锐特报收于30.8元，较前一交易日上涨0.36%，最新总市值为125.1亿元。该股当日开盘30.89元，最高32.15元，最低29.89元，成交额达4.38亿元，换手率为3.47%。公司近日发布公告称，奥锐特药业股份有限公司于2026年1月12日召开第三届董事会第十八次会议，审议通过《关于调整回购股份价格上限的议案》，将回购股份价格上限由不超过24.71元/股调整为不超过35.00元/股，回购方案其他内容不变。本次调整无需提交股东大会审议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200037459.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605116","BK0239"],"gpt_icon":0},{"id":"2602330895","title":"每周股票复盘：奥锐特（605116）累计回购2,627,238股","url":"https://stock-news.laohu8.com/highlight/detail?id=2602330895","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602330895?lang=zh_cn&edition=full","pubTime":"2026-01-11 02:19","pubTimestamp":1768069147,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘，奥锐特报收于30.69元，较上周的25.05元上涨22.51%。本周关注点公司公告汇总：奥锐特累计回购2,627,238股，占总股本0.65%。本次回购用于转换公司可转债，回购期限为2025年1月21日至2026年1月20日，预计回购金额为6,000万元至12,000万元。奥锐特药业股份有限公司关于可转债转股结果暨股份变动公告截至2025年12月31日，累计已有面值9,000元“奥锐转债”转为公司A股普通股，累计转股353股，占转股前总股本的0.0001%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011100000526.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605116"],"gpt_icon":0},{"id":"2601356863","title":"奥锐特涨10.00%，太平洋二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2601356863","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601356863?lang=zh_cn&edition=full","pubTime":"2026-01-08 15:33","pubTimestamp":1767857621,"startTime":"0","endTime":"0","summary":"今日奥锐特涨10.00%，收盘报28.27元。2025年11月1日，太平洋研究员周豫,乔露阳发布了对奥锐特的研报《Q3利润快速增长，多肽及小核酸加速放量》，该研报对奥锐特给出“买入”评级。研报中预测公司2025/26/27年营收为17.18/19.74/22.05亿元，归母净利润为4.61/5.92/7.10亿元，对应2025/26/27年PE为20/16/13X，持续给予“买入”评级。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为71.09%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010800019155.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605116","601099"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1774186869692,"stockEarnings":[{"period":"1week","weight":0.0093},{"period":"1month","weight":-0.0222},{"period":"3month","weight":0.1658},{"period":"6month","weight":0.1437},{"period":"1year","weight":0.2265},{"period":"ytd","weight":0.0355}],"compareEarnings":[{"period":"1week","weight":-0.0338},{"period":"1month","weight":-0.0306},{"period":"3month","weight":0.0171},{"period":"6month","weight":0.0359},{"period":"1year","weight":0.1608},{"period":"ytd","weight":-0.003}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"奥锐特药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"11515人(较上一季度减少2.17%)","perCapita":"35274股","listingDate":"2020-09-21","address":"浙江省台州市天台县八都工业园区","registeredCapital":"40618万元","survey":"　　奥锐特药业股份有限公司的主营业务是特色复杂原料药、医药中间体和制剂的研发、生产和销售。公司的主要产品是呼吸系统、心血管、抗感染、神经系统、抗肿瘤和女性健康类产品。","listedPrice":8.37},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.37.0","shortVersion":"4.37.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"奥锐特(605116)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供奥锐特(605116)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"奥锐特,605116,奥锐特股票,奥锐特股票老虎,奥锐特股票老虎国际,奥锐特行情,奥锐特股票行情,奥锐特股价,奥锐特股市,奥锐特股票价格,奥锐特股票交易,奥锐特股票购买,奥锐特股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"奥锐特(605116)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供奥锐特(605116)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}